āĻšā§āĻŽPHS âĸ FRA
add
Photocure ASA
ā§Ē.ā§Ģā§§âŦ
⧍ āĻā§āϞ, ā§§ā§§:ā§Ēā§Ŧ:ā§§ā§Ŧ PM GMT +⧍ · EUR · FRA · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§Ē.ā§Ēā§âŦ
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§Ē.ā§Ģā§§âŦ - ā§Ē.ā§Ģā§§âŦ
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Š.⧝ā§âŦ - ā§Ģ.ā§Šā§ĒâŦ
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§.ā§Ļā§Ļ
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(NOK) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ⧧⧍.ā§Ģā§ŠÂ āĻā§ | ā§Ŧ.ā§§ā§Ž% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ⧧⧍.ā§§ā§ŽÂ āĻā§ | ā§§ā§§.ā§§ā§Ŧ% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | -⧍ā§Ē.ā§§ā§§Â āϞāĻž | ā§Ŧ⧝.ā§Ēā§Ē% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | -ā§§.⧝⧍ | ā§ā§§.⧍ā§Ŧ% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | -ā§Ļ.ā§Ļ⧝ | ā§Ŧā§Ž.⧝ā§% |
EBITDA | ā§Š.ā§§ā§ŽÂ āϞāĻž | -⧝ā§Ģ.⧝ā§Ŧ% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§ā§Ē.ā§Šā§§% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(NOK) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ⧍ā§Ģ.⧝ā§Ģ āĻā§ | ā§Ļ.ā§Ē⧝% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§ā§Ļ.ā§Žā§Ŧ āĻā§ | -ā§Ļ.ā§Žā§Ģ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§¨ā§Š.ā§Ŧā§Â āĻā§ | ⧍.⧍ā§Ē% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ēā§.ā§§ā§ŽÂ āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ⧍.ā§Ŧā§Ŧ āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ļ.⧍ā§Ģ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§§.ā§¯ā§Š% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | -⧍.ā§Žā§§% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(NOK) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | -⧍ā§Ē.ā§§ā§§Â āϞāĻž | ā§Ŧ⧝.ā§Ēā§Ē% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ā§Ēā§Ļ.ā§ā§Ļ āϞāĻž | -ā§Ģā§§.ā§Ēā§Ŧ% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | ā§Ŧ.ā§Ģā§Â āϞāĻž | ā§Šā§Ļā§Š.ā§Ļā§% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Š.⧝ā§Ļ āĻā§ | -⧍⧝⧝.⧧⧍% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | -ā§Š.ā§Ēā§ŠÂ āĻā§ | -⧍,ā§Ŧā§Žā§¨.ā§Žā§§% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ā§Žā§Š.ā§Žā§¨Â āϞāĻž | ā§§ā§Ģ.ā§Ēā§% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy. Wikipedia
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
ā§§ā§¯ā§¯ā§Š
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§§ā§Ļā§Ļ